Granulocyte-Colony Stimulating Factor Nanocarriers for Stimulation of the Immune System (Part II): Dose-Dependent Biodistribution and In Vivo Antitumor Efficacy in Combination with Rituximab. [electronic resource]
Producer: 20190111Description: 804-812 p. digitalISSN:- 1520-4812
- Adjuvants, Immunologic -- administration & dosage
- Animals
- Antineoplastic Agents, Immunological -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Drug Carriers -- chemistry
- Drug Synergism
- Female
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Lymphoma -- drug therapy
- Mice
- Mice, Inbred C57BL
- Mice, SCID
- Nanoparticles -- chemistry
- Rituximab -- administration & dosage
- Silicon Dioxide -- chemistry
- Tissue Distribution
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.